Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

ClinicalTrials.gov ID: NCT05192200

Public ClinicalTrials.gov record NCT05192200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN OPEN LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE SAFETY OF PF-06823859 ADMINISTERED TO ADULT PARTICIPANTS ≥18 AND ≤80 WITH ACTIVE DERMATOMYOSITIS.

Study identification

NCT ID
NCT05192200
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • Anti-Beta Interferon (PF-06823859) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2021
Primary completion
Nov 19, 2023
Completion
Nov 19, 2023
Last update posted
Feb 5, 2025

2021 – 2023

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
University of Alabama at Birmingham, Department of Dermatology Birmingham Alabama 35294
Mayo Clinic Scottsdale Arizona 85259
Attune Health Research Inc. Beverly Hills California 90211
Mayo Clinic in Florida Jacksonville Florida 32224
KU Clinical Research Center - Clinical and Translational Science Unit (CTSU) Fairway Kansas 66205
KU Clinical and Translational Science Unit (CTSU) Rainbow Kansas City Kansas 66160
University of Kansas Medical Center Kansas City Kansas 66160
Brigham & Women's Hospital Boston Massachusetts 02115
Brigham and Women's Hospital - CTH Boston Massachusetts 02115
Center for Outpatient Health St Louis Missouri 63108
Washington University School of Medicine St Louis Missouri 63108
Washington University School of Medicine St Louis Missouri 63110
NYU Grossman School of Medicine, The Ronald O. Perelman Department of Dermatology New York New York 10016
NYU Langone Health Clinical Research Center New York New York 10016
NYU Langone Radiology - Ambulatory Care Center East 41st Street New York New York 10017
Mount Sinai Doctors Dermatology New York New York 10028
Icahn School of Medicine at Mount Sinai New York New York 10029
Cleveland Clinic Foundation Cleveland Ohio 44195
Center for Human Phenomic Science Philadelphia Pennsylvania 19104
University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM) Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05192200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05192200 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →